Zobrazeno 61 - 70
of 398
pro vyhledávání: '"Matteo Pirro"'
Autor:
Francesco Paciosi, Amirhossein Sahebkar, Vanessa Bianconi, Elisabetta Schiaroli, Sara Benedetti, Daniela Francisci, Matteo Pirro, Massimo Raffaele Mannarino, Ettore Marini
BACKGROUND Residual inflammation is thought to promote endothelial dysfunction and cardiovascular disease risk among people living with HIV (PLWH) receiving antiretroviral therapy (ART). Whether the neutrophil-to-lymphocyte ratio (NLR), a putative ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a4cea5e5558b4752f9e59963217568
https://hdl.handle.net/11391/1494808
https://hdl.handle.net/11391/1494808
Autor:
Giuseppe Batori, Filippo Figorilli, Vanessa Bianconi, Ettore Marini, Massimo Raffaele Mannarino, Francesco Grignani, Anna Gidari, Elena Cosentini, Matteo Pirro, Elisabetta Schiaroli, Daniela Francisci, Amirhossein Sahebkar
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5456
Journal of Clinical Medicine, Vol 10, Iss 5456, p 5456 (2021)
Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5456
Journal of Clinical Medicine, Vol 10, Iss 5456, p 5456 (2021)
Background: Endothelial injury can be induced by coronavirus disease 2019 (COVID-19) and seems to exert a crucial pathogenic role in its most severe clinical manifestations. We aimed to investigate the association between brachial artery flow-mediate
Autor:
Matteo Pirro, Paola Bronzo, Vanessa Bianconi, Amirhossein Sahebkar, Maciej Banach, Massimo Raffaele Mannarino
Publikováno v:
Archives of Medical Science : AMS
Introduction: Particulate matter exposure has been associated with the appearance and severity of several diseases, including viral infections The aim of this study was to investigate whether coronavirus disease 2019 (COVID-19) cases and deaths acros
Autor:
Amirhossein Sahebkar, Tannaz Jamialahmadi, Fabrizio Montecucco, Matteo Pirro, Maciej Banach, Khalid Al-Rasadi, Željko Reiner, Dina Radenkovic, Mahdi Hatamipour
Publikováno v:
Archives of Medical Science : AMS
Archives of Medical Science, Vol 16, Iss 3, Pp 490-496 (2020)
Archives of Medical Science, Vol 16, Iss 3, Pp 490-496 (2020)
Introduction: No proven drug and no immunisation are yet available for COVID-19 disease. The SARS-CoV-2 main protease (Mpro), a key coronavirus enzyme, which is a potential drug target, has been successfully crystallised. There is evidence suggesting
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
Mitophagy is a protected cellular process that is essential for autophagic removal of damaged mitochondria and for preservation of a healthy mitochondrial population. In the last years, a particular interest has been devoted in studying the effects o
Publikováno v:
Cellular & Molecular Biology Letters, Vol 25, Iss 1, Pp 1-17 (2020)
Cellular & Molecular Biology Letters
Cellular & Molecular Biology Letters
Apoptotic cells are rapidly engulfed and degraded by phagocytes through efferocytosis. Efferocytosis is a highly regulated process. It is triggered upon the activation of caspase-dependent apoptosis, which in turn promotes the expression of “eat me
Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
Autor:
Tannaz Jamialahmadi, Armita Mahdavi Gorabi, Matteo Pirro, Nasim Kiaie, Vanessa Bianconi, Amirhossein Sahebkar
Publikováno v:
Heart Failure Reviews. 26:1259-1272
Statins are well-known lipid-lowering drugs. The pleiotropic effects of statins have brought about some beneficial effects on improving the therapeutic outcomes of cell therapy and tissue engineering approaches. In this review, the impact of statins
Autor:
Angelo B. Cefalù, Raffaella Garbelotto, Giuliana Mombelli, Matteo Pirro, Paolo Rubba, Marcello Arca, Claudio Borghi, Katia Bonomo, Stefano Gonnelli, Katia Massaroni, Giampaolo Tirone, Maurizio Averna, Francesco Angelico, Francesco Cipollone, Enzo Corghi, Pompilio Faggiano, Cesare Greco, Luigina Guasti, Tiziano Lucchi, Carlo Sabba, Riccardo Sarzani, Pierfranco Terrosu, Alberto Zambon
Publikováno v:
Nutrition, metabolism, and cardiovascular diseases : NMCD. 32(11)
ODYSSEY APPRISE trial evaluated efficacy and safety of alirocumab in 994 patients with hypercholesterolemia and high CV risk in a real-life setting. The aim of the present report is to detail on the Italian cohort enrolled and treated in the trial.Th
Autor:
Vanessa Bainaconi, Maciej Banach, Tannaz Jamialahmadi, Massimo Raffaele Mannarino, Amirhossein Sahebkar, Nasim Kiaie, Matteo Pirro, Armita Mahdavi Gorabi
Publikováno v:
Progress in lipid research. 84
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or statins, are administered as first line therapy for hypercholesterolemia, both in primary and secondary prevention. There is a growing body of evidence showing that beyond t
Autor:
Massimiliano Ruscica, Peter E. Penson, Nicola Ferri, Cesare R. Sirtori, Matteo Pirro, G.B. John Mancini, Naveed Sattar, Peter P. Toth, Amirhossein Sahebkar, Carl J. Lavie, Nathan D. Wong, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Sonu Bhaskar, Bojko Bjelakovic, Eric Bruckert, Richard Ceska, Arrigo F.G. Cicero, Xavier Collet, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Zaneta Petrulioniene, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Maria-Corina Serban, Abdulla M.A. Shehab, Aleksandr B. Shek, Claudia Stefanutti, Tomasz Tomasik, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik
Publikováno v:
Progress in cardiovascular diseases, Philadelphia : W B Saunders Co-Elsevier Inc, 2021, vol. 67, p. 40-52
Progress in cardiovascular diseases, Vol. 67, p. 40-52 (2022)
Progress in cardiovascular diseases, Vol. 67, p. 40-52 (2022)
Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic in